Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics US
December 13 - 16, 2026
Marriott Marquis San Diego

Eli Bixby
Co-Founder and ML Lead at Cradle
Speaker

Profile

Eli Bixby is co-founder and ML Lead of Cradle, the Protein Engineering Platform for biological innovation, with teams in Amsterdam, Zurich, and the United States. Scientists at many of the biggest names in global pharmaceutical, industrial bio, agriculture and consumer goods — including Novonesis, AbbVie, and Novo Nordisk — use Cradle to design and optimize proteins for therapeutics, food, materials, and diagnostics, across more than 80 active R&D programs. Cradle has raised more than $100M to date, including a $73M Series B led by IVP. In 2026, Bayer and Lundbeck both entered multi-year collaborations with Cradle.

Agenda Sessions

  • Generative AI for End-to-End Biologics Engineering: Scalable, Robust and Lab-Validated

    , 12:35pm